{"id":232770,"date":"2025-10-29T21:26:04","date_gmt":"2025-10-29T21:26:04","guid":{"rendered":"https:\/\/www.newsbeep.com\/uk\/232770\/"},"modified":"2025-10-29T21:26:04","modified_gmt":"2025-10-29T21:26:04","slug":"the-off-label-treatment-that-helps-many-with-fibromyalgia","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/uk\/232770\/","title":{"rendered":"The Off-Label Treatment That Helps Many With Fibromyalgia"},"content":{"rendered":"<p>An unlikely, decades-old drug is gaining traction as a promising off-label treatment for <a href=\"https:\/\/emedicine.medscape.com\/article\/329838-overview\" class=\"cl_ref_article\" rel=\"nofollow noopener\" target=\"_blank\">fibromyalgia<\/a>, driven by a handful of studies and a growing number of anecdotal reports.<\/p>\n<p>Low-dose <a href=\"https:\/\/reference.medscape.com\/drug\/vivitrol-revia-naltrexone-343333\" class=\"cl_ref_drugs\" rel=\"nofollow noopener\" target=\"_blank\">naltrexone<\/a> (LDN), a medication originally developed to treat substance use disorders, is said to relieve the chronic pain, fatigue, and brain fog associated with the debilitating condition that afflicts <a href=\"https:\/\/protect.checkpoint.com\/v2\/r01\/___https:\/www.fmaware.org\/fibromyalgia-prevalence\/___.YzJ1OndlYm1kOmM6Zzo5MjNmMmZjMTRjN2FhMWE1YTkwMjFiNDYwMDNhZTVhNzo3OmM0MDc6ZDFiYmFiZDMxZmUwZTgxNzY1MTE1NmZhYTgwZGRlN2U2ODIyZThkY2RhN2U0ZWUxNzhlODRkODExMDc0NGJjZjpwOlQ6Rg\" rel=\"nofollow noopener\" target=\"_blank\">millions of Americans<\/a> but is difficult to treat.<\/p>\n<p>\u201cIt helps over 70% of my patients,\u201d said Scott Zashin, MD, a Dallas-based rheumatologist, and fellow of the American College of Rheumatology. \u201cI\u2019d say less than 10% need to stop it because of side effects.\u201d<\/p>\n<p>Used for decades at doses of 50-100 mg to treat opioid and <a href=\"https:\/\/emedicine.medscape.com\/article\/805084-overview\" class=\"cl_ref_article\" rel=\"nofollow noopener\" target=\"_blank\">alcohol use<\/a> disorders, the drug at that high dose binds to opioid receptors, blocking opioids from attaching to the receptors, so people don\u2019t get that feel-good sensation from booze or drugs.<\/p>\n<p>Early researchers found an unexpected result: \u201cWe noticed that when people tapered down to lower doses, their pain would also get better,\u201d said Arya Mohabbat, MD, assistant professor at the Mayo Clinic College of Medicine and Science, Rochester, Minnesota.<\/p>\n<p>Today the LDN trend is fueled primarily by success stories rather than large-scale trials.<\/p>\n<p>One of those stories is Dan Kenyon, age 45, who says LDN reduced his pain by more than half. \u201cIt has helped even more with brain fog, fatigue, and sleep,\u201d said Kenyon from Iowa, who was diagnosed in his early thirties after years of unexplained muscle soreness and fatigue.<\/p>\n<p>Despite the word-of-mouth buzz, though, many doctors are not aware of it, don\u2019t think there\u2019s enough evidence to prescribe it, or don\u2019t know how to prescribe it because it\u2019s not marketed by pharmaceutical companies. Still others see LDN as a low-risk, low-cost treatment option for fibromyalgia and other chronic pain conditions \u2014 and blame lack of pharmaceutical investment for impeding its progress.<\/p>\n<p>\u201cNaltrexone is an old cheap generic medication,\u201d said Mohabbat. \u201cJust because you formulate it to a lower dose, it doesn\u2019t change the patent, and they can\u2019t charge a lot of money for it.\u201d<\/p>\n<p>How Patients in Pain Are Finding LDN<\/p>\n<p>Looking back, Kenyon thinks the pain started when he was about 20. He had a physically demanding job in fire and water damage restoration, and his muscles would ache throughout the day, pain lingering into the next morning. Even after switching to less strenuous work \u2014 first running a retail store, then an online screen-printing business \u2014 his pain kept getting worse. Soon it was joined by <a href=\"https:\/\/emedicine.medscape.com\/article\/286759-overview\" class=\"cl_ref_article\" rel=\"nofollow noopener\" target=\"_blank\">depression<\/a> and <a href=\"https:\/\/emedicine.medscape.com\/article\/1187829-overview\" class=\"cl_ref_article\" rel=\"nofollow noopener\" target=\"_blank\">insomnia<\/a>. \u201cI got to a point where I just couldn\u2019t motivate myself to work anymore, my sales slowed down, and I didn\u2019t care,\u201d Kenyon said.<\/p>\n<p>At age 32, he saw a rheumatologist who diagnosed him with fibromyalgia. He tried <a href=\"https:\/\/reference.medscape.com\/drug\/neurontin-gralise-gabapentin-343011\" class=\"cl_ref_drugs\" rel=\"nofollow noopener\" target=\"_blank\">gabapentin<\/a>, but it gave him panic attacks and affected his balance. Weaning off it was so hard he was reluctant to try other medications.<\/p>\n<p>Browsing an online message board, he read success stories of people on LDN. His rheumatologist said he hadn\u2019t heard of naltrexone being used for chronic pain and wasn\u2019t willing to prescribe it. So Kenyon dropped it.<\/p>\n<p>\u201cThings started getting more painful for me last fall, so it sparked my interest in it again,\u201d Kenyon said. On Reddit, he learned how to get it prescribed online, purchased through a compounding pharmacy.<\/p>\n<p>\u201cI was nervous to try it but started with a very low dose and kept bumping it up every 6 or 7 days,\u201d Kenyon said. It took about 3 months to get to 4.5 mg, which is considered an effective dose. It was working: \u201cI have upwards of a 50% reduction in pain.\u201d<\/p>\n<p>Few Studies, Promising Results<\/p>\n<p>Several studies back LDN for fibromyalgia, though most are small.<\/p>\n<p>In 2013, a <a href=\"https:\/\/protect.checkpoint.com\/v2\/r01\/___https:\/pubmed.ncbi.nlm.nih.gov\/23359310\/___.YzJ1OndlYm1kOmM6Zzo5MjNmMmZjMTRjN2FhMWE1YTkwMjFiNDYwMDNhZTVhNzo3OjJiYmU6YzBjODAxOTgyMTdiNTA3NmVlZWM2NTJhMjVhYjBjZWNlNDNlMjQzYjkwOTFkNzcyMmI0NDE3NzYxNGI1MzgyMTpwOlQ6Rg\" rel=\"nofollow noopener\" target=\"_blank\">randomized controlled study of 31 women<\/a> with fibromyalgia found that LDN offered an average 29% reduction in pain vs 18% for women on a placebo. <a href=\"https:\/\/protect.checkpoint.com\/v2\/r01\/___https:\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3962576\/___.YzJ1OndlYm1kOmM6Zzo5MjNmMmZjMTRjN2FhMWE1YTkwMjFiNDYwMDNhZTVhNzo3OmVmZTM6N2FlMDI3ZDZiNTgwMWY0ZDY3NjY0MzgyMTBlNzM0ZjI3MzA0ZWFiMmEzMDZiYTkxZDZhZjVmNmVmYzUyMjI1MDpwOlQ6Rg\" rel=\"nofollow noopener\" target=\"_blank\">An analysis<\/a> of that data found that half the women on LDN were \u201cmuch improved\u201d or \u201cvery much improved\u201d \u2014 compared with just 20%-30% of patients who find meaningful improvement on current fibromyalgia-approved medications, said study author Jarred Younger, PhD, director of the Neuroinflammation, Pain and Fatigue Laboratory at The University of Alabama at Birmingham.<\/p>\n<p>A 2023 <a href=\"https:\/\/protect.checkpoint.com\/v2\/r01\/___https:\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10135963\/___.YzJ1OndlYm1kOmM6Zzo5MjNmMmZjMTRjN2FhMWE1YTkwMjFiNDYwMDNhZTVhNzo3OjM5N2Q6MzNmZWVmNTkyNTcyMTM2NGFhY2Q4NDJiNzkyZjk2ZTU1OGEzYjI2MjZhOWVhNTliNjE3OWE5ZTdjNjFmZGRkYTpwOlQ6Rg\" rel=\"nofollow noopener\" target=\"_blank\">cohort study of LDN for pain conditions<\/a> included 115 people, most having fibromyalgia. The study found that 65% reported a benefit in their pain and other symptoms. A <a href=\"https:\/\/protect.checkpoint.com\/v2\/r01\/___https:\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10039621\/___.YzJ1OndlYm1kOmM6Zzo5MjNmMmZjMTRjN2FhMWE1YTkwMjFiNDYwMDNhZTVhNzo3OmEyYjA6MzAzZThiNGM2MDBjZWI1ODg4OGE4Mjk0MTk2OTY5NTA0Mjc3MzUzYzQ1MDljYzgyY2FhMzU2M2YyMzQ4ODUyNzpwOlQ6Rg\" rel=\"nofollow noopener\" target=\"_blank\">review of nine studies<\/a> found LDN effective in managing fibromyalgia symptoms, and so did a <a href=\"https:\/\/protect.checkpoint.com\/v2\/r01\/___https:\/pubmed.ncbi.nlm.nih.gov\/39344363\/___.YzJ1OndlYm1kOmM6Zzo5MjNmMmZjMTRjN2FhMWE1YTkwMjFiNDYwMDNhZTVhNzo3OmFiZTg6OWEzZDhmNTFlYjRiY2M4Y2JiNjU3ZTRkNDU3OTBmNDhjNTdhZTFmYjZmZDI0MDhmYzlkMmU1M2E2MjE3NjQ1ODpwOlQ6Rg\" rel=\"nofollow noopener\" target=\"_blank\">2024 review<\/a> of randomized controlled trials.<\/p>\n<p>Further research shows pain improvements in other conditions, like Crohn\u2019s disease and <a href=\"https:\/\/protect.checkpoint.com\/v2\/r01\/___https:\/www.medscape.com\/s\/viewarticle\/long-haul-2025a1000gb5___.YzJ1OndlYm1kOmM6Zzo5MjNmMmZjMTRjN2FhMWE1YTkwMjFiNDYwMDNhZTVhNzo3OjMwMTU6MzlmMTNkODljYjhhMzU5MzI0ODZiMTY5ZGZlNmRhNzMzODJlOGE5M2JiZjRlZDYxMzFhMTE1ZDljYmY2YmViZjpwOlQ6Rg\" rel=\"nofollow noopener\" target=\"_blank\">Long COVID<\/a>.<\/p>\n<p>To be sure, more research is needed. \u201cWe need a double blinded randomized trial for 12 months that looks at side effects and how people do functionally,\u201d said Mohabbat.<\/p>\n<p>\u201cThere\u2019s still that question mark in the air,\u201d said Younger. \u201cClearly it helps a lot of people, but without the study, a lot of physicians aren\u2019t going to want to use it,\u201d he said. But the buzz is growing. \u201cLDN comes up in every medical conference.\u201d<\/p>\n<p>How LDN Works<\/p>\n<p>LDN is thought to tamp down nerve inflammation responsible for many of the symptoms of fibromyalgia like pain, fatigue, malaise, brain fog, and <a href=\"https:\/\/emedicine.medscape.com\/article\/219557-overview\" class=\"cl_ref_article\" rel=\"nofollow noopener\" target=\"_blank\">flu<\/a>-like symptoms. In fibromyalgia, glial cells, which support neurons, are activated, causing an inflammatory response. LDN blocks a receptor that activates glial cells, stopping the inflammatory cascade.<\/p>\n<p>Like any medication, it doesn\u2019t help everyone and won\u2019t completely get rid of symptoms. But for those it helps, it can be life changing.<\/p>\n<p>Jane Lamping, age 53, who lives in San Diego, was diagnosed with fibromyalgia in 2014, and has tried a long list of medications \u2014 among them <a href=\"https:\/\/reference.medscape.com\/drug\/ultram-conzip-tramadol-343324\" class=\"cl_ref_drugs\" rel=\"nofollow noopener\" target=\"_blank\">Tramadol<\/a>, Lyrica, Cymbalta, Fetzima, Mobic, gabapentin, Toradol injections. But she continued to have many flares, which left her unable to keep a job. Like many with fibromyalgia, Lamping had to carefully manage her exertion to try to prevent flares. In 2022, her doctor, who had been following the research on LDN, suggested she try it.<\/p>\n<p>It reduced her pain, brain fog, and fatigue. \u201cIt has helped immensely. I do still get flares and pain cycles. But they are less frequent, and it has reduced the intensity as well,\u201d she said. A bonus: It helped with her migraines.<\/p>\n<p>A Crowd-Sourced Approach in the Absence of Robust Data<\/p>\n<p>Kenyon, like many people, learned how to take LDN from online groups and shared it with his physician \u2014 a crucial step, Zashin said. \u201cThe window for optimally dosing naltrexone is very small and requires high accuracy,\u201d said Younger. Like any medication, it carries potential risks.<\/p>\n<p>The most common side effect is vivid dreams, which can be disturbing. These affect about a third of people who take it but can be minimized by not taking it right before bed. Other side effects, which studies suggest affect up to 10% of people, include headaches and gastrointestinal symptoms.<\/p>\n<p>For some, LDN can temporarily cause their pain to worsen.<\/p>\n<p>It happened to Michelle Smedley, age 62, of Lake Havasu City, Arizona. About 12 years ago, she decided to try LDN for her fibromyalgia, which she\u2019s had since she was a teenager. Her doctor started her on 3 mg, which is considered a relatively high starting dose today. \u201cI had more pain, was achy, tired, had bad insomnia, but my doctor kept telling me to hang in there,\u201d she said.<\/p>\n<p>Finally, in the first week of month 4, she started to feel better and showed steady improvement. The pain went from about an 8 on a pain scale to a 6. Today, she said, she\u2019s 80% herself. \u201cBeing a grandmother on LDN is delightful,\u201d she said. \u201cI can play with them, swim with them. I wasn\u2019t able to do that raising my son.\u201d<\/p>\n<p>Younger recommends starting at about 1 mg or even less if you\u2019re sensitive to medications, holding there for a couple of weeks, and then increasing the dose to 2 or 3 mg, holding there, and then increasing again. The therapeutic dose is considered 4.5 mg, but some people get relief at a lower dose, and some have to go up to about 6 mg.<\/p>\n<p>Zashin, who has been prescribing LDN for 15 years, starts patients at 0.5 mg and increases it weekly until they find an effective dose. \u201cThere\u2019s a sweet spot for some people where they might do better at 2 than 3 mg,\u201d he said. On average, his patients land between 3 and 4.5 mg.<\/p>\n<p>\u201cAlmost all of the side effects are transient, while your body is getting adjusted\u201d \u2014 which can take up to 2-3 months, said Mohabbat.<\/p>\n<p>LDN is often considered a last resort approach, after people have failed with other medications. But some believe it could be used sooner.<\/p>\n<p>\u201cIt\u2019s actually one of my first line treatments for fibromyalgia,\u201d said Zashin. \u201cI\u2019ve seen it change people lives dramatically.\u201d<\/p>\n<p>\u201cI think there\u2019s no problem with trying the other medications first, but the majority of people will not respond to them,\u201d Younger said. \u201cIf it\u2019s not helping, I\u2019d quickly move to LDN.\u201d<\/p>\n<p>LDN is available at compounding pharmacies and some online shops, such as AgelessRx, because it\u2019s sometimes marketed as a longevity medication. Typical out-of-pocket cost ranges from $30 to $100 a month, and it is not covered by insurance.<\/p>\n<p>\u201cBecause the side effects seem to be minimal, I think it is an appropriate thing for a physician to consider trying for their patients,\u201d said Younger.<\/p>\n","protected":false},"excerpt":{"rendered":"An unlikely, decades-old drug is gaining traction as a promising off-label treatment for fibromyalgia, driven by a handful&hellip;\n","protected":false},"author":2,"featured_media":232771,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42],"tags":[102,6591,56,54,55],"class_list":{"0":"post-232770","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-medication","10":"tag-uk","11":"tag-united-kingdom","12":"tag-unitedkingdom"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/232770","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/comments?post=232770"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/232770\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media\/232771"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media?parent=232770"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/categories?post=232770"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/tags?post=232770"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}